Novel Strategies for Targeting HIV-CNS Reservoirs without Reactivation (R21)

The summary for the Novel Strategies for Targeting HIV-CNS Reservoirs without Reactivation (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Novel Strategies for Targeting HIV-CNS Reservoirs without Reactivation (R21): This funding opportunity announcement invites research grant applications focused on: identifying HIV-1-infected cells in the central nervous system (CNS) compartment that are latently infected; developing strategies for targeting these latently infected cells; and aiming to achieve viral silencing leading to inhibition of viral production, without the need for pro-viral reactivation.
Federal Grant Title: Novel Strategies for Targeting HIV-CNS Reservoirs without Reactivation (R21)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-MH-17-100
Type of Funding: Grant
CFDA Numbers: 320744, 320745, 320746, 320747
CFDA Descriptions: Mental Health Research Grants; Drug Abuse and Addiction Research Programs; Extramural Research Programs in the Neurosciences and Neurological Disorders
Current Application Deadline: Sep 9, 2016
Original Application Deadline: Sep 9, 2016
Posted Date: Apr 6, 2016
Creation Date: Apr 6, 2016
Archive Date: Oct 10, 2016
Total Program Funding:
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award: none
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Independent school districts
Private institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Small businesses
County governments
City or township governments
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
Native American tribal governments (Federally recognized)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-17-100.html
Grant Announcement Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
More Grants from the National Institutes of Health
Summer Institute for Research Education in Biostatistics (R25 - Clinical Trials Not Allowe...
In Vivo Synaptic Function in Alzheimers Disease and Related Dementias (R21 Clinical Trial ...
Novel Nucleic Acid Sequencing Technology Development (R21 Clinical Trial Not Allowed)
Novel Nucleic Acid Sequencing Technology Development (R43/R44 Clinical Trial Not Allowed)
Novel Nucleic Acid Sequencing Technology Development (R01 Clinical Trial Not Allowed)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com